SEC Comment Letter for Cellectar Biosciences, Inc. (CLRB) (CIK 0001279704) (CLRB) — Jun 20, 2018
Cellectar Biosciences, Inc. (CLRB) (CIK 0001279704)
Date: June 20, 2018 · CIK: 0001279704 · Accession: 0000000000-18-019011
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-225675
Letter
June 20, 2018 James V. Caruso President and Chief Executive Officer Cellectar Biosciences, Inc. 3301 Agriculture Drive Madison, WI 53716 Re:Cellectar Biosciences, Inc. Registration Statement on Form S-1 Filed June 15, 2018 File No. 333-225675 Dear Mr. Caruso: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Irene Paik at 202-551-6553 with any questions. Division of Corporation Finance Office of Healthcare & Insurance cc: Joshua B. Erekson, Esq.
Show Raw Text
June 20, 2018
James V. Caruso
President and Chief Executive Officer
Cellectar Biosciences, Inc.
3301 Agriculture Drive
Madison, WI 53716
Re:Cellectar Biosciences, Inc.
Registration Statement on Form S-1
Filed June 15, 2018
File No. 333-225675
Dear Mr. Caruso:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Irene Paik at 202-551-6553 with any questions.
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Joshua B. Erekson, Esq.